Digestive System Neuroendocrine Tumor — Trials

Digestive System Neuroendocrine Tumor — Trials · CancerIndex

Clinical trials

Registered studies

256 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05364944	A Study to Assess the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Debio 4126 in Participants With Acromegaly or Functioning Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)(OXTEND-01)	terminated	Phase 1	19	Debiopharm International SAINDUSTRY	8	Nov 17, 2025	clinicaltrials
NCT02110563	Phase I, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Solid Tumors, Multiple Myeloma, or Lymphoma	terminated	Phase 1	50	Dicerna Pharmaceuticals, Inc., a Novo Nordisk company